# Pawzmedi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pawzmedi

- Industry: Healthcare
- Headquarters: Chuncheon-si, South Korea
- Website: http://www.baropet.co.kr/
- Latest round: Seed (Nov 11, 2024)
- Investors on record: 2

## About

Based in Gangwon-do, South Korea, founded in 2022, Baropet Co., Ltd. trading under the name Pawzmedi, operates as a healthcare company that is designed to assess a pet's body composition, which encompasses fat, muscle, and hydration levels, allowing veterinarians and pet owners to understand a pet's overall health, track variations in body composition, and recognize potential health concerns. In November 2024, Pawzmedi raised seed funding from Bluepoint Partners. Pawzmedi offers advanced healthcare solutions for pets, with its main product, the BaroBody, a diagnostic device that measures a pet's body composition. The firm's device helps pet owners and veterinarians assess health factors like obesity and nutritional imbalances. Pawzmedi serves a range of clients, including pet owners, veterinary clinics, and animal healthcare providers. The company is dedicated to pet health, as shown by its involvement in events such as the 2023 DengDang Run dog marathon.

## Funding rounds

- Seed, Nov 11, 2024 — Bluepoint Partners
- Seed, Nov 1, 2024 — Bluepoint Partners, Korea Tech Incubator for Startup

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed
- Korea Tech Incubator for Startup — Seed